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Effects of Removal and Reconstitution of Troponin and Tropomyosin
on Ca2þ-Activated Tension Generation in Cardiac Myofibrils
Beatrice Scellini, Nicoletta Piroddi, Corrado Poggesi, Chiara Tesi.
Universita` di Firenze, Firenze, Italy.
Tropomyosin is an essential component in the regulation of muscle contraction.
A method has been described to remove endogenous tropomyosin (Tm) and
troponin (Tn) and replace them with exogenous proteins into rabbit psoas myo-
fibrils (Siththanandan et al., Biophys. J., 2007, suppl. 626a). In the present study
the endogenous Tm and Tn are replaced into cardiac mouse myofibrils by
a modification of that method. Endogenous Tm and Tn were extracted by wash-
ing cardiac mouse myofibrils in a low ionic strength solution at pH 8.0. The
wash was repeated several times to increase the amount of extracted Tm.
The reconstitution of thin filament regulatory proteins was made in a rigor so-
lution in two steps, first adding Tm and then Tn. To measure the effects of this
procedure, samples of myofibrils were analyzed at different stages of the pro-
tocol (control, extracted, reconstituted) both functionally (by loss and regain of
Ca2þ -dependent regulation) and by SDS-PAGE. The success of the exchange
was determined by mechanical measurements of calcium dependent force ac-
tivation on the reconstituted myofibrils. Small bundles of cardiac myofibrils
were mounted in a force recording apparatus and activated by rapidly switching
between low and high Ca2þ solutions (Tesi et al., Biophys. J., 2002, 83, 2142-
2151). Maximal isometric tension was 30-35% lower in the reconstituted myo-
fibrils than in control myofibrils but the rate of force activation (kACT) and that
of force redevelopment (kTR) was the same in the two myofibril groups. The
effectiveness of Tm replacement in human cardiac myofibrils is under investi-
gation. This approach can be used to test the functional impact of Tmmutations
responsible for human cardiomyopathies. Supported by Telethon-Italy
GGP07133.
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Length-Tension Relationships Are Similar Between Cardiac Myocytes
And Skeletal Muscle Fibers
Laurin M. Hanft, Kerry S. McDonald.
University of Missouri, Columbia, MO, USA.
According to the Frank-Starling relationship increased ventricular volume in-
creases ventricular output, which helps match peripheral energy supply with
demand. The cellular basis for this relationship is, in large part, the myofila-
ment length-tension relationship. The length-tension relationship in maximally
activated skinned preparations is relatively shallow and similar between cardiac
myocytes and skeletal muscle fibers. During twitch activations the length ten-
sion relationship becomes steeper in both cardiac and skeletal muscle; however,
it remains unclear whether length dependence of tension differs between stri-
ated muscle cell types during submaximal activations. The purpose of this study
was to compare myofilament length-tension relationships between cardiac my-
ocytes, fast-twitch and slow twitch skeletal muscle fibers during half-maximal
calcium activations. For these experiments, passive and active sarcomere
length-tension relationships were characterized in skinned rat left ventricular
cardiac myocytes, fast-twitch and slow-twitch skeletal muscle fibers. For active
length-tension relationships, cells were mounted between a force transducer
and motor and activated to yield 50-65% maximal force after which isometric
force was measured over a range of ascending limb sarcomere lengths moni-
tored by IonOptix SarLen system. Passive tension was considerably greater
in cardiac myocytes (3.5 5 2.5 kN/m2 at 2.30 5 0.04mm) compared to both
fast-twitch (1.1 5 0.8 kN/m2 at 2.70 5 0.07mm) and slow-twitch (1.4 5
0.5 kN/m2 at 2.70 5 0.07mm) muscle fibers. Active myofilament length-ten-
sion relationships were considerably shallower in slow-twitch fibers compared
to fast-twitch fibers. Interestingly, cardiac myocytes exhibited two distinct
populations of length-tension relationships, one nearly identical to fast-twitch
fibers and the other similar to slow-twitch fibers. These results indicate that
cardiac myocytes exhibit length-tension relationships very similar to skeletal
muscle fibers. The finding of two populations of cardiac myocyte length-ten-
sion relationships suggests a mode for adjusting Frank-Starling relationships
following acute and/or chronic ventricular adaptations.
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Effect of Varying Mutant Troponin C Content on Contractile Properties
of Striated Muscle
Erik R. Feest, An-yue Tu, Charles Luo, Sarah G. Nowakowski,
Michael Regnier.
University of Washington, Seattle, WA, USA.
Genetic therapies show much potential as novel, long-term treatments for skel-
etal and cardiac muscle diseases. Troponin C (TnC), a subunit of troponin, is
a particularly promising target for genetic therapies, as it is involved in thin fil-
ament activation, Ca2þ signaling and Ca2þ handling. Specifically, expressionof engineered TnC mutants with altered Ca2þ binding properties has the poten-
tial to restore normal contractile function in diseased/damaged muscle with ab-
normal Ca2þ properties. We are, therefore, studying skeletal TnC (sTnC) and
cardiac TnC (cTnC) mutants that we, and others, have demonstrated affect
Ca2þ signaling: F27W, M80Q sTnC and I60Q sTnC, and cTnC L48Q and
I61Q. Since various amounts of mutant proteins are incorporated into the myo-
filaments following viral vector administration of mutant TnC cDNA, the goal
of this study was to determine the minimal amount of protein expression nec-
essary to alter contractility in striated muscle. In preliminary studies, different
ratios of F27W, M80Q to WT sTnC (100:1, N¼4; 50:50, N¼4; 25:75, N¼4;
1:100, N¼6; C0¼1mg/mL for all TnCs) were reconstituted into demembra-
nated skeletal muscle fibers. Following reconstitution, the maximal Ca2þ acti-
vated force (Fmax) was 9050.02% (WT), 8350.03% (100:1), 9250.04%
(50:50) and 9050.01% (25:75) of pre-extracted Fmax (216515 mN/mm
2).
Ca2þ sensitivity was significantly enhanced for all ratios (100:1,
pCa50¼6.1750.02, p<0.001; 50:50, pCa50¼5.9050.03, p<0.05; 25:75,
pCa50¼6.0150.01, p<0.01) as compared to WT (pCa50¼5.7650.04). These
preliminary data indicate that <25% of the mutant protein is required to alter
contractility without changing the maximal Ca2þ activated force. Continuing
work will identify the minimal level of mutant TnC incorporation in striated
muscle that significantly alters pCa50 and the rate force develops.
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Local Detection Of Intracellular Reactive Oxygen Species In Single
Intact Contracting Skeletal Muscle Fibers
Luke Michaelson, Christopher W. Ward, George G. Rodney.
Univerisity of Maryland School of Nursing, Baltimore, MD, USA.
Skeletal muscles produce low levels of reactive oxygen species (ROS) under
resting conditions while during contractile activity the rate of ROS production
increases. Low levels of ROS production may act to stimulate adaptive re-
sponses in skeletal muscle, while increased ROS dependent oxidation at sarco-
plasmic reticulum, myofilaments and other EC coupling components likely
lead to decrements in contractile function. Multiple sites exist for ROS produc-
tion, including mitochondria and NADPH oxidase; however, the contribution
of each of these and the factors that regulate the increased production of
ROS during contractile activity remains to be determined. Here we use repet-
itive field stimulation of single FDB myofibers as a model of ROS secondary to
repetitive activity. In FDB’s loaded with the cytosolic, non-specific ROS probe
DCFH, we have imposed intermittent (0.5 Hz) trains (150msec, 0.5msec sq.
pulse @, 50Hz) of tetanic stimulation to establish a reliable in vitro model
for activity dependent ROS production. In recent studies with this model, we
have begun to explore site dependent generation of ROS with a redox sensitive
variant of green fluorescent protein (roGFP) that is targeted to the mitochondria
(mito-roGFP). Following cDNA electroporation in vivo, expression of mito-
roGFP, and FDB isolation, we report evidence of the fidelity and specificity
of this probe in mitochondria and the activity dependent mitochondrial redox
status during our stimulation paradigm.
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Comparison of W7 binding to the Regulatory N-domain of Human
Cardiac Troponin C in the absence and presence of the Switch Region of
Human Cardiac Troponin I
Marta Oleszczuk, Ryan M.B. Hoffman, Monica X. Li, Brian D. Sykes.
University of Alberta, Edmonton, AB, Canada.
cTnC-cTnI interaction plays a critical role in transmitting the Ca2þ-signal to the
other myofilament proteins in heart muscle contraction. As such, the cTnC-cTnI
interface constitutes a logical target for cardiotonic drugs that can modulate the
Ca2þ-sensitivity in cardiomyocytes. We have shown that W7, a calmodulin an-
tagonist, binds specifically to the N-domain of cTnC, and this binding can occur
concurrently with the switch region of cTnI. Moreover, we have shown that that
the affinity of W7 for cNTnCCa2þ in the cTnC3Ca2þcTnI34-71cTnI128-163
complex is ~2-fold weaker than for the isolated cNTnCCa2þ. This suggests
that W7 plays role in inhibiting the cTnC-cTnI interaction in the activation of
muscle contraction. In this study, we determined the dissociation constants for
W7 binding to cNTnCCa2þin complex with two versions of the switch region
of cTnI (cTnI144-163 and cTnI147-163). The results showed that the N-terminal
three residue extension in cTnI144-163 over cTnI147-163 decreases the W7 affinity
by ~3.5-fold (KD¼ 0.145 0.04 mM forW7 binding cNTnCCa2þcTnI147-163
andKD¼ 0.525 0.16mM forW7 binding cNTnCCa2þcTnI144-163). This ob-
servation suggests competitive binding between W7 and the N-terminus of the
switch region of cTnI to the cNTnCCa2þ. We have determined the NMR struc-
tures of cNTnCCa2þW7 and cNTnCCa2þcTnI147-163W7 complexes. This
pair of structures provides a detailed understandingof themechanismunderlying
the mode of action of W7 on the cTnC-cTnI interface and generates structural
insights into the features that are important for the design of cardiotonic drugs.
